The Collagen Factors of Rapid Progression of Keratoconus in Children.
KCLD
1 other identifier
observational
160
1 country
1
Brief Summary
The purpose of this observational study was to understand the differences in clinical features and mechanisms of keratoconus between children and adults. The main questions it aimed to answer as follows: (1) to understand the characteristics of keratoconus in Chinese children. (2) to observe corneal stromal cells at the cytological level using in vivo corneal laser confocal microscopy and explore the pathogenesis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 14, 2023
CompletedFirst Submitted
Initial submission to the registry
November 26, 2024
CompletedFirst Posted
Study publicly available on registry
December 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 13, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 13, 2025
CompletedDecember 9, 2024
December 1, 2024
2 years
November 26, 2024
December 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Thinnest corneal thickness
Measurement of the thinnest point corneal thickness using the Three-Dimensional Anterior Segment Analyzer.
1 year
Kmax
Measurement of the maximum keratometry from the anterior corneal surface using the Pentacam Three-Dimensional Anterior Segment Analyzer.
1 year
ISV
Measurement of the index of surface variance of corneal front surface using the Pentacam Three-Dimensional Anterior Segment Analyzer.
1 year
IVA
Measurement of the index of vertical asymmetry of the corneal anterior surface using the Pentacam Three-Dimensional Anterior Segment Analyzer.
1 year
IHA
Measurement of the index of height asymmetry of the corneal anterior surface using the Pentacam Three-Dimensional Anterior Segment Analyzer.
1 year
IHD
Measurement of the index of height decentration the corneal anterior surface using the Pentacam Three-Dimensional Anterior Segment Analyzer.
1 year
CBI
Measurement of the corvis biomechanical index of cornea using the Corneal Biomechanical Analyzer.
1 year
TBI
Measurement of the tomographical biomechanical index of cornea using the Corneal Biomechanical Analyzer.
1 year
SPA1
Measurement of the stiffness parameter at the first applanation of cornea using the Corneal Biomechanical Analyzer.
1 year
SSI
Measurement of the stress-strain index of cornea using the Corneal Biomechanical Analyzer.
1 year
Corneal stromal cell density
Measurement of the corneal stromal cell density using in vivo corneal confocal microscopy.
1 year
Mutations in collagen related genes
The expressions and mutations in collagen related genes(COL4A3, COL4A4 COL5A1, COL6A2, TGFBI, LOX, MMP9, TIMP1) using the DNA Sequencing Technology.
1 year
Secondary Outcomes (4)
Frame best corrected visual acuity
1 year
Spherical power
1 year
Cylindrical power
1 year
Axial length
1 year
Study Arms (4)
Keratoconus group of children
Keratoconus group of adult
Control group of children
Control group of adult
Interventions
Observe the clinical natural changes of eye parameters of the subjects.
Eligibility Criteria
Consistently enrolled subjects aged between 10 and 50 years old with keratoconus and myopic astigmatism who visited the refractive clinic from April 2023 to April 2024
You may qualify if:
- ① Patients with keratoconus who visit the refractive clinic.
- The height of the posterior corneal surface is greater than 16 microns under the Pentacam corneal topography.
- ARTAve \< 424 microns, ARTMax \< 339 microns.
- Clinical non-inflammatory or traumatic corneal thinning and corneal astigmatism.
- Aged between 10 and 50 years old, no gender restrictions.
- Agree to accept and complete follow-up examinations on time. ④ I and my guardian understand and agree to participate in this clinical trial and sign the informed consent form.
You may not qualify if:
- ① There is a history of contact lens wearing in the last four weeks.
- poor fixation and can not cooperate with the examination. ③ History of eye trauma and surgery (including corneal collagen cross-linking surgery).
- History of other related eye diseases: corneal disease, glaucoma, retinal choroid disease, etc..
- ⑤ severe eye diseases affecting imaging such as dry eye, conjunctivitis and pterygium.
- ⑥ Any systemic disease affecting eye morphology and refractive interstitium.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhongshan Ophthalmic Center,Sun Yat-Sen University
Guangzhou, Guangdong, China
Related Links
Biospecimen
Venous blood DNA sequencing analysis
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2024
First Posted
December 9, 2024
Study Start
April 14, 2023
Primary Completion
April 13, 2025
Study Completion
April 13, 2025
Last Updated
December 9, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- The IPD and supporting information will be permanently available (start date) on December 30, 2025.
- Access Criteria
- Any non-commercial scholars and institutions can apply to access the IPD and supporting information.
We will share our Study protocol, Statistical analysis plan, Informed consent form, Clinical study report.